The alleged misconduct was by 12 sales representatives from Questcor Pharmaceuticals, which Mallincrodt acquired in August 2014.
Prosecutors claim that the drugmaker, between 2009 and 2013, “wined and dined” physicians in order to improve Medicare prescription rates and boost profits. The alleged acts, which resulted in false claims being submitted to Medicare, are a violation of the federal Anti-Kickback Statute and the False Claims Act.
Read the full news release here.
More articles on pharmacy:
Civica Rx says it isn’t afraid of competition
Cigna rolls out plan to fully cover expensive gene therapies
Rutgers to close 3 on-campus pharmacies
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
